These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 31231091)

  • 1. Identification of CDKN2A variants in breast cancer patients in Pakistan.
    Khan R; Aftab A; Tabassum S; Hussain HMJ; Hameed A; Mahmood H; Munir F; Bukhari I
    Genes Genet Syst; 2019 Jul; 94(3):117-122. PubMed ID: 31231091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDKN2A/P16INK4A variants association with breast cancer and their in-silico analysis.
    Aftab A; Shahzad S; Hussain HMJ; Khan R; Irum S; Tabassum S
    Breast Cancer; 2019 Jan; 26(1):11-28. PubMed ID: 30039340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CDKN2a common variants: 148 Ala/Thr and 500 C/G in 3' UTR, and their association with clinical course of melanoma.
    Lamperska KM; Przybyła A; Kycler W; Mackiewicz A
    Acta Biochim Pol; 2007; 54(1):119-24. PubMed ID: 17351674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single nucleotide polymorphism in the 3'untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare.
    Kumar R; Smeds J; Berggren P; Straume O; Rozell BL; Akslen LA; Hemminki K
    Int J Cancer; 2001 Nov; 95(6):388-93. PubMed ID: 11668523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical course of bladder neoplasms and single nucleotide polymorphisms in the CDKN2A gene.
    Sakano S; Berggren P; Kumar R; Steineck G; Adolfsson J; Onelöv E; Hemminki K; Larsson P
    Int J Cancer; 2003 Mar; 104(1):98-103. PubMed ID: 12532425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma.
    Bisio A; Nasti S; Jordan JJ; Gargiulo S; Pastorino L; Provenzani A; Quattrone A; Queirolo P; Bianchi-Scarrà G; Ghiorzo P; Inga A
    Hum Mol Genet; 2010 Apr; 19(8):1479-91. PubMed ID: 20093296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cdkn2a encodes functional variation of p16INK4a but not p19ARF, which confers selection in mouse lung tumorigenesis.
    Herzog CR; Noh S; Lantry LE; Guan KL; You M
    Mol Carcinog; 1999 Jun; 25(2):92-8. PubMed ID: 10365910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDKN2A loss and PIK3CA mutation in myoepithelial-like metaplastic breast cancer.
    Bartels S; van Luttikhuizen JL; Christgen M; Mägel L; Luft A; Hänzelmann S; Lehmann U; Schlegelberger B; Leo F; Steinemann D; Kreipe H
    J Pathol; 2018 Jul; 245(3):373-383. PubMed ID: 29708279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of cyclin-dependent kinase inhibitor 2A/B with increased risk of developing breast cancer.
    Seifi S; Pouya F; Rahmani M; Mehramiz M; Rastgar-Moghadam A; Gharib M; Rahmani F; Shahidsales S; Hassanian SM; Khazaei M; Dadjoo P; Parvin SS; Yazdinezhad Y; Parizadeh SMR; Ferns GA; Fathi M; Avan A
    J Cell Physiol; 2020 Jun; 235(6):5141-5145. PubMed ID: 31721206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A common variant of CDKN2A (p16) predisposes to breast cancer.
    Debniak T; Górski B; Huzarski T; Byrski T; Cybulski C; Mackiewicz A; Gozdecka-Grodecka S; Gronwald J; Kowalska E; Haus O; Grzybowska E; Stawicka M; Swiec M; Urbański K; Niepsuj S; Waśko B; Góźdź S; Wandzel P; Szczylik C; Surdyka D; Rozmiarek A; Zambrano O; Posmyk M; Narod SA; Lubinski J
    J Med Genet; 2005 Oct; 42(10):763-5. PubMed ID: 15879498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDKN2A-positive breast cancers in young women from Poland.
    Debniak T; Cybulski C; Górski B; Huzarski T; Byrski T; Gronwald J; Jakubowska A; Kowalska E; Oszurek O; Narod SA; Lubiński J
    Breast Cancer Res Treat; 2007 Jul; 103(3):355-9. PubMed ID: 17061045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-146b-5p mediates p16-dependent repression of IL-6 and suppresses paracrine procarcinogenic effects of breast stromal fibroblasts.
    Al-Ansari MM; Aboussekhra A
    Oncotarget; 2015 Oct; 6(30):30006-16. PubMed ID: 26338965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees.
    Harland M; Mistry S; Bishop DT; Bishop JA
    Hum Mol Genet; 2001 Nov; 10(23):2679-86. PubMed ID: 11726555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.
    Della Torre G; Pasini B; Frigerio S; Donghi R; Rovini D; Delia D; Peters G; Huot TJ; Bianchi-Scarra G; Lantieri F; Rodolfo M; Parmiani G; Pierotti MA
    Br J Cancer; 2001 Sep; 85(6):836-44. PubMed ID: 11556834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk.
    Debniak T; Scott R; Masojc B; Serrano-Fernández P; Huzarski T; Byrski T; Debniak B; Górski B; Cybulski C; Medrek K; Kurzawski G; van de Wetering T; Maleszka R; Kładny J; Lubinski J
    Int J Cancer; 2006 Dec; 119(11):2597-602. PubMed ID: 16988943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan.
    Rashid MU; Muhammad N; Faisal S; Amin A; Hamann U
    Breast Cancer Res Treat; 2014 Jun; 145(3):775-84. PubMed ID: 24800917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma.
    Ghasimi S; Wibom C; Dahlin AM; Brännström T; Golovleva I; Andersson U; Melin B
    J Neurooncol; 2016 May; 127(3):483-92. PubMed ID: 26839018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the CDKN2A (p16INK4a) gene in microdissected sporadic primary melanomas.
    Kumar R; Lundh Rozell B; Louhelainen J; Hemminki K
    Int J Cancer; 1998 Jan; 75(2):193-8. PubMed ID: 9462707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation.
    Smeds J; Berggren P; Ma X; Xu Z; Hemminki K; Kumar R
    Carcinogenesis; 2002 Apr; 23(4):645-55. PubMed ID: 11960918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDKN2A and CDK4 variants in Latvian melanoma patients: analysis of a clinic-based population.
    Pjanova D; Engele L; Randerson-Moor JA; Harland M; Bishop DT; Newton Bishop JA; Taylor C; Debniak T; Lubinski J; Kleina R; Heisele O
    Melanoma Res; 2007 Jun; 17(3):185-91. PubMed ID: 17505264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.